Quality scores do not predict discrepant statistical significances among meta-analyses on different targets of glycemic control in type 2 diabetes

Journal of Clinical Epidemiology

Volumn 66, Issue 12, 2013, Pages 1356-1366

  Passon, Anna M ^a   Drabik, Anna ^a   Sawicki, Peter T ^a  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

Glucose control; Meta Analysis; Methodological quality; Systematic review; Type 2 diabetes; Vascular diseases

Indexed keywords

GLUCOSE;

ARTICLE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; QUALITY CONTROL; QUESTIONNAIRE; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW;

EID: 84886948518     PISSN: 08954356     EISSN: 18785921     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2013.06.006     Document Type: Review

References (68)

1. D.L. Sackett, S.E. Strauss, W.S. Richardson, W. Rosenberg, and R.B. Haynes Evidence-based medicine: how to practice and teach EBM 2nd ed. 2000 Churchill-Livingstone Edinburgh, UK
2. B. Phillips, C. Ball, D. Sackett, D. Badenoch, S. Straus, and B. Haynes Levels of evidence 2009 Centre for Evidence-based Medicine Oxford, UK Available at http://www.cebm.net/index.aspx?o=4590 Accessed March 8, 2011
3. H. Bastian, P. Glasziou, and I. Chalmers Seventy-five trials and eleven systematic reviews a day: how will we ever keep up? PLoS Med 7 9 2010 e1000326
4. M. Egger, K. Dickersin, and G.D. Smith Problems and limitations in conducting systematic reviews M. Egger, G.D. Smith, D.G. Altman, Systematic reviews in health care: meta-analysis in context 2005 BMJ Publishing Group London, UK 43 68
5. T. Mazzone Intensive glucose lowering and cardiovascular disease prevention in diabetes: reconciling the recent clinical trial data Circulation 122 2010 2201 2211
6. McCulloch D. Glycemic control and vascular complications in type 2 diabetes mellitus. UpDate Clin Decis Support Syst 2010. Available at http://www.uptodate.com/contents/glycemic-control-and-vascular-complications-in- type-2-diabetes-mellitus?source=see-link&anchor=H19#H24. Accessed March 23, 2011.
7. IDF Clinical Guidelines Task Force Global guideline for type 2 diabetes 2005 International Diabetes Federation Brussels, Belgium 1 82
8. Canadian Diabetes Association Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada Can J Diabetes 32 Suppl 1 2008 1 215
9. E. Dixon, M. Hameed, F. Sutherland, D.J. Cook, and C. Doig Evaluating meta-analyses in the general surgical literature: a critical appraisal Ann Surg 241 3 2005 450 459
10. A. Delaney, S.M. Bagshaw, A. Ferland, B. Manns, K.B. Laupland, and C.J. Doig A systematic evaluation of the quality of meta-analyses in the critical care literature Crit Care 9 5 2005 R575 R582
11. S.J. Senn Overstating the evidence: double counting in meta-analysis and related problems BMC Med Res Methodol 9 2009 10
12. K. Rerkasem, and P.M. Rothwell Meta-analysis of small randomized controlled trials in surgery may be unreliable Br J Surg 97 4 2010 466 469
13. D. Moher, A. Liberati, J. Tetzlaff, D.G. Altman PRISMA Group Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement Ann Intern Med 151 2009 264 269
14. A.D. Oxman, and G.H. Guyatt Validation of an index of the quality of review articles J Clin Epidemiol 44 1991 1271 1278
15. B.J. Shea, J.M. Grimshaw, G.A. Wells, M. Boers, N. Andersson, and C. Hamel Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews BMC Med Res Methodol 7 2007 10
16. A. Liberati, D.G. Altman, J. Tetzlaff, C. Mulrow, P.C. Gøtzsche, and J.P. Ioannidis The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration BMJ 339 2009 b2700
17. National Institute for Health and Clinical Excellence Type 2 diabetes. The management of type 2 diabetes 2008 NICE clinical guideline 66 London, UK
18. M. Kendall A new measure of rank correlation Biometrika 30 1-2 1938 81 89
19. R Development Core Team R: A language and environment for statistical computing 2011 R Foundation for Statistical Computing Vienna, Austria
20. I. Tkác Effect of intensive glycemic control on cardiovascular outcomes and all-cause mortality in type 2 diabetes: overview and metaanalysis of five trials Diabetes Res Clin Pract 86 Suppl 1 2009 S57 S62
21. J. Ma, W. Yang, N. Fang, W. Zhu, and M. Wei The association between intensive glycemic control and vascular complications in type 2 diabetes mellitus: a meta-analysis Nutr Metab Cardiovasc Dis 19 9 2009 596 603
22. Q. Wang, and P. Han Intensive glucose control compared with standard therapy in type 2 diabetes: a systemic review Chin J Evid-based Med 9 7 2009 774 782
23. Institute for Quality and Efficiency in Health Care [Article in German] Nutzenbewertung einer langfristigen, normnahen Blutzuckersenkung bei Patienten mit Diabetes mellitus Typ 2 2011 IQWiG-Berichte Cologne, Germany 87 Rapid Report A05-07
24. E.S. Huang, J.B. Meigs, and D.E. Singer The effect of interventions to prevent cardiovascular disease in patients with type 2 diabetes mellitus Am J Med 111 2001 633 642
25. C. Stettler, S. Allemann, P. Jüni, C.A. Cull, R.R. Holman, and M. Egger Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: meta-analysis of randomized trials Am Heart J 152 2006 27 38
26. T.N. Kelly, L.A. Bazzano, V.A. Fonseca, T.K. Thethi, K. Reynolds, and J. He Systematic review: glucose control and cardiovascular disease in type 2 diabetes Ann Intern Med 151 2009 394 403
27. E. Mannucci, M. Monami, C. Lamanna, F. Gori, and N. Marchionni Prevention of cardiovascular disease through glycemic control in type 2 diabetes: a meta-analysis of randomized clinical trials Nutr Metab Cardiovasc Dis 19 9 2009 604 612
28. K.K. Ray, S.R. Seshasai, S. Wijesuriya, R. Sivakumaran, S. Nethercott, and D. Preiss Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials Lancet 373 2009 1765 1772
29. Control Group, F.M. Turnbull, C. Abraira, R.J. Anderson, R.P. Byington, and J.P. Chalmers Intensive glucose control and macrovascular outcomes in type 2 diabetes Diabetologia 52 2009 2288 2298
30. S.P. Marso, K.F. Kennedy, J.A. House, and D.K. McGuire The effect of intensive glucose control on all-cause and cardiovascular mortality, myocardial infarction and stroke in persons with type 2 diabetes mellitus: a systematic review and meta-analysis Diab Vasc Dis Res 7 2 2010 119 130
31. H. Wu, M. Xu, D. Zou, Q. Han, and X. Hu Intensive glycemic control and macrovascular events in type 2 diabetes mellitus: a meta-analysis of randomized controlled trials Chin Med J (Engl) 123 2010 2908 2913
32. C.Y. Zhang, A.J. Sun, S.N. Zhang, C.N. Wu, M.Q. Fu, and G. Xia Effects of intensive glucose control on incidence of cardiovascular events in patients with type 2 diabetes: a meta-analysis Ann Med 42 4 2010 305 315
33. R. Boussageon, T. Bejan-Angoulvant, M. Saadatian-Elahi, S. Lafont, C. Bergeonneau, and B. Kassaï Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials BMJ 343 2011 d4169
34. B. Hemmingsen, S.S. Lund, C. Gluud, A. Vaag, T. Almdal, and C. Hemmingsen Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus Cochrane Database Syst Rev 6 2011 CD008143
35. The Action to Control Cardiovascular Risk in Diabetes Study Group, H.C. Gerstein, M.E. Miller, R.P. Byington, D.C. Goff Jr., and J.T. Bigger Effects of intensive glucose lowering in type 2 diabetes N Engl J Med 358 2008 2545 2559
36. ADVANCE Collaborative Group, A. Patel, S. MacMahon, J. Chalmers, B. Neal, and L. Billot Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes N Engl J Med 358 2008 2560 2572
37. W. Bagg, L.D. Plank, G. Gamble, P.L. Drury, N. Sharpe, and G.D. Braatvedt The effects of intensive glycaemic control on body composition in patients with type 2 diabetes Diabetes Obes Metab 3 2001 410 416
38. H.J. Dargie, P.R. Hildebrandt, G.A. Riegger, J.J. McMurray, S.O. McMorn, and J.N. Roberts A randomized, placebo-controlled trial assessing the effects of rosiglitazone on echocardiographic function and cardiac status in type 2 diabetic patients with New York Heart Association Functional Class I or II Heart Failure J Am Coll Cardiol 49 2007 1696 1704
39. K. Malmberg, L. Ryden, S. Efendic, J. Herlitz, P. Nicol, and A. Waldenström Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year J Am Coll Cardiol 26 1995 57 65
40. K. Malmberg, L. Ryden, H. Wedel, K. Birkeland, A. Bootsma, and K. Dickstein Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity Eur Heart J 26 2005 650 661
41. L.X. Guo, Q. Pan, X.X. Wang, H. Li, L.N. Zhang, and J.M. Chi Effect of short term intensive multitherapy on carotid intima-media thickness in patients with newly diagnosed type 2 diabetes mellitus Chin Med J (Engl) 121 2008 687 690
42. P.D. Home, S.J. Pocock, H. Beck-Nielsen, P.S. Curtis, R. Gomis, and M. Hanefeld Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial Lancet 373 2009 2125 2135
43. C. Hage, A. Norhammar, L. Grip, K. Malmberg, N. Sarkar, and B. Svane Glycaemic control and restenosis after percutaneous coronary interventions in patients with diabetes mellitus: a report from the Insulin Diabetes Angioplasty study Diab Vasc Dis Res 6 2 2009 71 79
44. L.A. Jaber, H. Halapy, M. Fernet, S. Tummalapalli, and H. Diwakaran Evaluation of a pharmaceutical care model on diabetes management Ann Pharmacother 30 1996 238 243
45. M. Shichiri, H. Kishikawa, Y. Ohkubo, and N. Wake Long-term results of the Kumamoto study on optimal diabetes control in type 2 diabetic patients Diabetes Care 23 Suppl 2 2000 B21 B29
46. A. Melidonis, A. Stefanidis, S. Tournis, S. Manoussakis, S. Handanis, and M. Zairis The role of strict metabolic control by insulin infusion on fibrinolytic profile during an acute coronary event in diabetic patients Clin Cardiol 23 3 2000 160 164
47. J.A. Dormandy, B. Charbonnel, D.J. Eckland, E. Erdmann, M. Massi-Benedetti, and I.K. Moules Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial Lancet 366 2005 1279 1289
48. Y.V. Lapina, D.N. Filatov, V.Y. Mareev, OIu Narusov, M.G. Bolotina, and M.V. Shestakova [Article in Russian] Effect of strict glycemic control on clinical state and course of the disease in patients with chronic heart failure and Type II diabetes mellitus. Results of the REMBO "Rational Effective Multicomponent Therapy in the Struggle against DiaBetes Mellitus in Patients With COngestive Heart Failure" Study Kardiologiya 48 9 2008 17 27
49. F.J. Service, J.R. Daube, P.C. O'Brien, B.R. Zimmerman, C.J. Swanson, and M.D. Brennan Effect of blood glucose control on peripheral nerve function in diabetic patients Mayo Clinic Proc 58 5 1983 283 289
50. A. Stefanidis, A. Melidonis, S. Tournis, M. Zairis, S. Handanis, and D. Beldekos Effect of intravenous insulin administration on left ventricular performance during non-ST-elevation acute coronary events in patients with diabetes mellitus Am J Cardiol 91 2003 1237 1240
51. P. Gaede, P. Vedel, N. Larsen, G.V. Jensen, H.H. Parving, and O. Pedersen Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes N Engl J Med 348 2003 383 393
52. The University Group Diabetes Program Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes: VIII. Evaluation of insulin therapy: final report Diabetes 31 Suppl 5 1982 1 78
53. UK Prospective Diabetes Study (UKPDS) Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet 352 1998 837 853
54. UK Prospective Diabetes Study (UKPDS) Group Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) Lancet 352 1998 854 865
55. C. Abraira, J. Colwell, F. Nuttall, C.T. Sawin, W. Henderson, and J.P. Comstock Cardiovascular events and correlates in the veterans affairs diabetes feasibility trial. Veterans affairs cooperative study on glycemic control and complications in type II diabetes Arch Intern Med 157 1997 181 188
56. W. Duckworth, C. Abraira, T. Moritz, D. Reda, N. Emanuele, and P.D. Reaven Glucose control and vascular complications in veterans with type 2 diabetes N Engl J Med 360 2009 129 139
57. A. Becker, F.E.E. van der Does, V.W.M. van Hinsbergh, R.J. Heine, L.M. Bouter, and C.D.A. Stehouwer Improvement of glycaemic control in type 2 diabetes: favourable changes in blood pressure, total cholesterol and triglycerides, but not in HDL cholesterol, fibrinogen, von Willebrand factor and (pro)insulin Neth J Med 61 4 2003 129 136
58. J.M. Yang, X.H. Guo, and X. Yu [Article in Chinese] Long-term intensive glycemic and lipid control ameliorates the carotid intima medial thickness in type 2 diabetes mellitus Beijing Da Xue Xue Bao 39 6 2007 649 652
59. J.S. Yudkin, and B. Richter Concerns about meta-analysis of glucose control and cardiovascular disease in type 2 diabetes Ann Intern Med 152 2010 63 64
60. C. Minelli, J.R. Thompson, K.R. Abrams, A. Thakkinstian, and J. Attia The quality of meta-analyses of genetic association studies: a review with recommendations Am J Epidemiol 170 2009 1333 1343
61. B.G. Dijkman, J.A. Abouali, B.W. Kooistra, H.J. Conter, R.W. Poolman, and A.V. Kulkarni Twenty years of meta-analyses in orthopaedic surgery: has quality kept up with quantity? J Bone Joint Surg Am 92 2010 48 57
62. B. Tendal, E. Nüesch, J.P. Higgins, P. Jüni, and P.C. Gøtzsche Multiplicity of data in trial reports and the reliability of meta-analyses: empirical study BMJ 343 2011 d4829
63. A.P. Jones, T. Remmington, P.R. Williamson, D. Ashby, and R.L. Smyth High prevalence but low impact of data extraction and reporting errors were found in Cochrane systematic reviews J Clin Epidemiol 58 2005 741 742
64. G. Cordoba, L. Schwartz, S. Woloshin, H. Bae, and P.C. Gøtzsche Definition, reporting, and interpretation of composite outcomes in clinical trials: systematic review BMJ 341 2010 c3920
65. J.P.T. Higgins, and S. Green Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011] 2011 The Cochrane Collaboration Cambridge, UK Available at http://www.cochrane-handbook.org Accessed August 31, 2012
66. A.D. Furlan, V. Pennick, C. Bombardier, M. van Tulder, Editorial Board Cochrane back review group 2009 updated method guidelines for systematic reviews in the Cochrane back review group Spine (Phila Pa 1976) 34 18 2009 1929 1941
67. A. Delaney, S.M. Bagshaw, A. Ferland, K. Laupland, B. Manns, and C. Doig The quality of reports of critical care meta-analyses in the Cochrane Database of Systematic Reviews: an independent appraisal Crit Care Med 35 2 2007 589 594
68. A.M. Moseley, M.R. Elkins, R.D. Herbert, C.G. Maher, and C. Sherrington Cochrane reviews used more rigorous methods than non-Cochrane reviews: survey of systematic reviews in physiotherapy J Clin Epidemiol 62 2009 1021 1030